Avidity Biosciences
RNA
#1841
Rank
S$13.98 B
Marketcap
S$92.84
Share price
-0.39%
Change (1 day)
116.50%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: S$13.98 Billion

As of December 2025 Avidity Biosciences has a market cap of S$13.98 Billion. This makes Avidity Biosciences the world's 1841th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2025

End of year Market Cap

Year Marketcap Change
2025S$13.98 B186.48%
2024S$4.88 B415.99%
2023S$0.94 B-52.14%
2022S$1.97 B31.19%
2021S$1.50 B18.95%
2020S$1.26 B

End of Day market cap according to different sources

On Dec 21st, 2025 the market cap of Avidity Biosciences was reported to be:

S$14.04 Billion
by Nasdaq info icon info icon
S$14.04 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
PTC Therapeutics
PTCT
S$8.15 B-41.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
S$1.05 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
S$2.86 B-79.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
S$3.84 B-72.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
S$0.15 B-98.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
S$14.08 B 0.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$184.83 B 1,221.27%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$126.76 B 806.17%๐Ÿ‡ฌ๐Ÿ‡ง UK